| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 33,534 | 34,252 | 34,897 | 34,908 | | Cost of Revenue | 6,490 | 6,578 | 6,984 | 7,606 | | | Gross Profit | 27,044 | 27,674 | 27,913 | 27,302 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,780 | 15,202 | 14,172 | 13,128 | | Non Recurring | 5,930 |
-
|
-
|
-
| | Others | 10,516 | 4,996 | 4,512 | 16,286 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,182) | 7,476 | 9,229 | (2,112) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (3,182) | 7,476 | 9,229 | (2,112) | | Interest Expense | 3,513 | 3,737 | 3,823 | 3,994 | | Income Before Tax | (6,695) | 3,739 | 5,406 | (6,106) | | Income Tax Expense | (2,630) | 893 | 1,211 | (3,009) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,065) | 2,846 | 4,195 | (3,097) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,065) | 2,846 | 4,195 | (3,097) | | Preferred Stock And Other Adjustments | (512) | (511) | (341) |
-
| | | Net Income Applicable To Common Shares | ($4,577) | $2,335 | $3,854 | ($3,097) |
|
0.51% Nasdaq 
0.22 (2.27%) 
Income Statement
